tolvaptan has been researched along with transforming growth factor alpha in 1 studies
| Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (transforming growth factor alpha) | Trials (transforming growth factor alpha) | Recent Studies (post-2010) (transforming growth factor alpha) |
|---|---|---|---|---|---|
| 967 | 172 | 786 | 4,301 | 44 | 623 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boertien, WE; Engels, GE; Gansevoort, RT; Harskamp, LR; Meijer, E; van Goor, H; van Oeveren, W | 1 |
1 other study(ies) available for tolvaptan and transforming growth factor alpha
| Article | Year |
|---|---|
Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Case-Control Studies; EGF Family of Proteins; Epidermal Growth Factor; Female; Glomerular Filtration Rate; Heparin-binding EGF-like Growth Factor; Humans; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Polycystic Kidney, Autosomal Dominant; Severity of Illness Index; Tolvaptan; Transforming Growth Factor alpha | 2015 |